G. Fuchs

University of Minnesota — United States

Medicine · Health Sciences

18h-index1.8kcitations59works0.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(46), Neurological disorders and treatments(27), Genetic Neurodegenerative Diseases(11), Botulinum Toxin and Related Neurological Disorders(6), Neurotransmitter Receptor Influence on Behavior(3)

Publications59 total

Mutant ATXN1 impacts human and mouse microglia and contributes to cognitive, mood, and motor deficits in SCA1 mice
2026Open Access
An expanded polyglutamine in ATAXIN1 results in a loss-of-function that exacerbates severity of Multiple Sclerosis in an EAE mouse model
Journal of Neuroinflammation·2025· 1 citedOpen Access
An expanded polyglutamine in ATAXIN1 results in a loss-of-function that exacerbates severity of Multiple Sclerosis in an EAE mouse model
2025Open Access
Intraindividual Variability of Nonmotor Fluctuations in Advanced Parkinson’s Disease
Journal of Parkinson s Disease·2015· 16 citedOpen Access
Quantitative assessment of non-motor fluctuations in Parkinson’s disease using the Non-Motor Symptoms Scale (NMSS)
Journal of Neural Transmission·2015· 73 cited
Influence of the Nonergot Dopamine Agonist Piribedil on Vigilance in Patients With Parkinson Disease and Excessive Daytime Sleepiness (PiViCog-PD)
Clinical Neuropharmacology·2014· 36 cited
Das „aut idem“ Problem in der Parkinson-Therapie
Aktuelle Neurologie·2013· 1 cited
Nonmotor fluctuations in Parkinson disease
Neurology·2013· 346 cited
Das "aut idem" Problem in der Parkinson-Therapie The "aut idem" Problem in the Therapy for Parkinson's Disease
2013
Reduced Body Mass Index in Parkinson’s Disease
The Journal of Nervous and Mental Disease·2012· 18 cited
Requirements for Parkinson’s disease pharmacotherapy from the patients’ perspective: a questionnaire-based survey
Current Medical Research and Opinion·2012· 16 cited
Indikationsstellung für invasive medikamentöse Therapien
Aktuelle Neurologie·2011· 1 cited
Validity of the DESPAR questionnaire as a new screening tool for depression in Parkinson’s disease
Basal Ganglia·2011· 4 cited
Treatment of dysautonomia in extrapyramidal disorders
Journal of Neurology·2011· 14 cited
P133 Nonmotor fluctuations in Parkinson’s disease: Evaluation of frequency and severity of nonmotor symptoms in off states of advanced Parkinson’s disease
Basal Ganglia·2011
P104 Dopamine agonists and demented Parkinson’s disease patients: Really a no go?
Basal Ganglia·2011
Depression beim idiopathischen Parkinson-Syndrom – Teil 2: Therapie und Management
Fortschritte der Neurologie · Psychiatrie·2010· 9 cited
Non-motor Symptoms Questionnaire und Scale für das idiopathische Parkinson-Syndrom
Der Nervenarzt·2010· 43 cited
Brauchen wir die frühzeitige tiefe Hirnstimulation beim Morbus Parkinson?
Fortschritte der Neurologie · Psychiatrie·2010· 4 cited
Validation of a German version of the NMSS (Non-Motor Symptom assessment Scale)
Klinische Neurophysiologie·2010· 2 cited
page 1 of 3Next →

Frequent Co-authors

Wolfgang H. Jost(14), Georg Ebersbach(14), Alexander Storch(13), Per Odin(12), Gerd Reifschneider(9), Christine Schneider(8), Heinz Reichmann(7), W. Kuhn(6), Michael Bauer(5), К. Ray Chaudhuri(4), H. Przuntek(4), Heinz Reichmann(4), A. Hornig(4), Martin Wolz(3), Rainer Koch(3), Friedrich Foerster(3), Jochen Fahrenberg(3), H. Baas(3), Daniela Berg(2), Dirk Woitalla(2)